Texas Public Radio: Drug proven to slow Alzheimer’s receives FDA accelerated approval but caveats remain Shared By: contributorJanuary 17, 2023 Arash Salardini, MD, and Jeremy Tanner, MD, Neurology, Glenn Biggs Institute, were quoted in this story. Read More Share This Article!
